Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/35690079 below:

Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database

Affiliations

• ¹ Department of Radiology, Duke University, Durham, North Carolina; Vice Chair, National Mammography Database. Electronic address: lars.grimm@duke.edu.
• ² NYU Langone Health, New York, New York.
• ³ Radiology Associates of Albuquerque, Albuquerque, New Mexico; Chair, National Mammography Database.
• ⁴ Vice President, Quality Programs, American College of Radiology, Reston, Virginia.
• ⁵ Director, Quality Registries, American College of Radiology, Reston, Virginia.
• ⁶ American College of Radiology, Reston, Virginia.
• ⁷ American College of Radiology, Harvey L. Neimann Health Institute, Reston, Virginia.
• ⁸ Vice Chair, Women's Imaging, Chief of Breast Imaging, Northwestern Medicine, Chicago, Illinois.
• ⁹ Chief of Breast Imaging, Vice Chair of Quality Assurance and Strategic Development, University of Pittsburgh, Pittsburgh, Pennsylvania; Chair, National Radiology Data Registry.

• PMID: 35690079
• PMCID: PMC9174535
• DOI: 10.1016/j.jacr.2022.04.008

Item in Clipboard

Lars J Grimm et al. J Am Coll Radiol. 2022 Aug.

• ¹ Department of Radiology, Duke University, Durham, North Carolina; Vice Chair, National Mammography Database. Electronic address: lars.grimm@duke.edu.
• ² NYU Langone Health, New York, New York.
• ³ Radiology Associates of Albuquerque, Albuquerque, New Mexico; Chair, National Mammography Database.
• ⁴ Vice President, Quality Programs, American College of Radiology, Reston, Virginia.
• ⁵ Director, Quality Registries, American College of Radiology, Reston, Virginia.
• ⁶ American College of Radiology, Reston, Virginia.
• ⁷ American College of Radiology, Harvey L. Neimann Health Institute, Reston, Virginia.
• ⁸ Vice Chair, Women's Imaging, Chief of Breast Imaging, Northwestern Medicine, Chicago, Illinois.
• ⁹ Chief of Breast Imaging, Vice Chair of Quality Assurance and Strategic Development, University of Pittsburgh, Pittsburgh, Pennsylvania; Chair, National Radiology Data Registry.

• PMID: 35690079
• PMCID: PMC9174535
• DOI: 10.1016/j.jacr.2022.04.008

Item in Clipboard

Purpose: The aim of this study was to quantify the initial decline and subsequent rebound in breast cancer screening metrics throughout the coronavirus disease 2019 (COVID-19) pandemic.

Methods: Screening and diagnostic mammographic examinations, biopsies performed, and cancer diagnoses were extracted from the ACR National Mammography Database from March 1, 2019, through May 31, 2021. Patient (race and age) and facility (regional location, community type, and facility type) demographics were collected. Three time periods were used for analysis: pre-COVID-19 (March 1, 2019, to May 31, 2019), peak COVID-19 (March 1, 2020, to May 31, 2020), and COVID-19 recovery (March 1, 2021, to May 31, 2021). Analysis was performed at the facility level and overall between time periods.

Results: In total, 5,633,783 screening mammographic studies, 1,282,374 diagnostic mammographic studies, 231,390 biopsies, and 69,657 cancer diagnoses were analyzed. All peak COVID-19 metrics were less than pre-COVID-19 volumes: 36.3% of pre-COVID-19 for screening mammography, 57.9% for diagnostic mammography, 47.3% for biopsies, and 48.7% for cancer diagnoses. There was some rebound during COVID-19 recovery as a percentage of pre-COVID-19 volumes: 85.3% of pre-COVID-19 for screening mammography, 97.8% for diagnostic mammography, 91.5% for biopsies, and 92.0% for cancer diagnoses. Across various metrics, there was a disproportionate negative impact on older women, Asian women, facilities in the Northeast, and facilities affiliated with academic medical centers.

Conclusions: COVID-19 had the greatest impact on screening mammography volumes, which have not returned to pre-COVID-19 levels. Cancer diagnoses declined significantly in the acute phase and have not fully rebounded, emphasizing the need to increase outreach efforts directed at specific patient population and facility types.

Keywords: COVID-19; breast biopsies; breast cancer; diagnostic mammography; screening mammography.

Copyright © 2022 American College of Radiology. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Monthly volume of screening and…

Monthly volume of screening and diagnostic mammographic examinations from the National Mammography Database…

Monthly volume of screening and diagnostic mammographic examinations from the National Mammography Database from March 1, 2019, through May 31, 2021. The green, red, and yellow boxes refer to the 3-month-long pre-COVID-19, peak COVID-19, and COVID-19 recovery periods, respectively, used for analysis. COVID-19 = coronavirus disease 2019.

Monthly volume of biopsies performed…

Monthly volume of biopsies performed and cancer diagnoses from the National Mammography Database…

Monthly volume of biopsies performed and cancer diagnoses from the National Mammography Database from March 1, 2019, through May 31, 2021. The green, red, and yellow boxes refer to the 3-month-long pre-COVID-19, peak COVID-19, and COVID-19 recovery periods, respectively, used for analysis. COVID-19 = coronavirus disease 2019.

Percentage of diagnostic mammographic examinations…

Percentage of diagnostic mammographic examinations during the peak COVID-19 versus the pre-COVID-19 period…

Percentage of diagnostic mammographic examinations during the peak COVID-19 versus the pre-COVID-19 period by age decade with fitted trend line. COVID-19 = coronavirus disease 2019.

Monthly and cumulative cancer deficits…

Monthly and cumulative cancer deficits from March 2020 to May 2021 on the…

Monthly and cumulative cancer deficits from March 2020 to May 2021 on the basis of the average monthly cancer diagnoses from March 2019 to February 2020.

• Screening Mammography Recovery After COVID-19 Pandemic Facility Closures: Associations of Facility Access and Racial and Ethnic Screening Disparities.

  Lehman CD, Mercaldo SF, Wang GX, Dontchos BN, Specht MC, Lamb LR. Lehman CD, et al. AJR Am J Roentgenol. 2022 Jun;218(6):988-996. doi: 10.2214/AJR.21.26890. Epub 2021 Nov 24. AJR Am J Roentgenol. 2022. PMID: 34817192

• Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic.

  Crivellaro P, Tafur M, George R, Muradali D. Crivellaro P, et al. Eur Radiol. 2022 Jan;32(1):613-620. doi: 10.1007/s00330-021-08117-z. Epub 2021 Jun 18. Eur Radiol. 2022. PMID: 34143286 Free PMC article.

• The role of facility and patient mix factors on recovery of screening and diagnostic mammography volumes following the initial COVID-19 pandemic wave.

  Lomahan S, Rauscher GH, Murphy AM. Lomahan S, et al. Cancer Med. 2023 May;12(9):10877-10888. doi: 10.1002/cam4.5793. Epub 2023 Mar 16. Cancer Med. 2023. PMID: 36924321 Free PMC article.

• The Impact of the COVID-19 Pandemic on Breast Imaging.

  Freer PE. Freer PE. Radiol Clin North Am. 2021 Jan;59(1):1-11. doi: 10.1016/j.rcl.2020.09.008. Epub 2020 Sep 22. Radiol Clin North Am. 2021. PMID: 33222992 Free PMC article. Review.

• A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis.

  Li T, Nickel B, Ngo P, McFadden K, Brennan M, Marinovich ML, Houssami N. Li T, et al. Breast. 2023 Feb;67:78-88. doi: 10.1016/j.breast.2023.01.001. Epub 2023 Jan 5. Breast. 2023. PMID: 36646004 Free PMC article. Review.

• Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study.

  Guével E, Priou S, Lamé G, Wassermann J, Bey R, Uzan C, Chatellier G, Belkacemi Y, Tannier X, Guillerm S, Flicoteaux R, Gligorov J, Cohen A, Benderra MA, Teixeira L, Daniel C, Hersant B, Tournigand C, Kempf E; Assistance Publique-Hôpitaux de Paris (AP-HP) Cancer Group, a Cancer Research Application on Big Data (CRAB) initiative. Guével E, et al. Cancer Med. 2023 Nov;12(22):20918-20929. doi: 10.1002/cam4.6637. Epub 2023 Nov 1. Cancer Med. 2023. PMID: 37909210 Free PMC article.

• The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review.

  Elemes S, Stachteas P, Haidich AB, Mamopoulos A, Smyrnakis E. Elemes S, et al. In Vivo. 2023 Jul-Aug;37(4):1455-1476. doi: 10.21873/invivo.13230. In Vivo. 2023. PMID: 37369493 Free PMC article. Review.

• Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic?

  Fefferman ML, Chan K, Cotler J, Thompson DM, Bleicher RJ, Kurtzman SH, Dietz JM, Yao K. Fefferman ML, et al. Breast Cancer Res Treat. 2025 May;211(1):11-22. doi: 10.1007/s10549-025-07617-6. Epub 2025 Jan 26. Breast Cancer Res Treat. 2025. PMID: 39865151

• Rates of newly diagnosed breast cancer at commission on cancer facilities during the early phase of the COVID-19 pandemic.

  Fefferman M, Kuchta K, Wang CH, Nicholson K, Kopkash K, Pesce C, Poli E, Smith TW, Yao K. Fefferman M, et al. Cancer Med. 2024 Jan;13(1):e6874. doi: 10.1002/cam4.6874. Epub 2023 Dec 22. Cancer Med. 2024. PMID: 38140789 Free PMC article.

• Examining Associations between Source of Cancer Information and Mammography Behavior among Black Church-Going Women.

  Carter BJ, Chen TA, Cho D, Connors SK, Siddiqi AD, McNeill LH, Reitzel LR. Carter BJ, et al. Int J Environ Res Public Health. 2022 Oct 11;19(20):13004. doi: 10.3390/ijerph192013004. Int J Environ Res Public Health. 2022. PMID: 36293643 Free PMC article.

1. 1. Moreland A., Herlihy C., Tynan M.A. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement—United States, March 1–May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1198–1203. - PMC - PubMed
2. 1. Bae K.T., Tao C., Gurel S., et al. Effect of patient weight and scanning duration on contrast enhancement during pulmonary multidetector CT angiography. Radiology. 2007;242:582–589. - PubMed
3. 1. Lowry K.P., Bissell M., Miglioretti D.L., et al. Breast biopsy recommendations and breast cancers diagnosed during the COVID-19 pandemic. Radiology. 2022;33:287–294. - PMC - PubMed
4. 1. Sharpless N.E. COVID-19 and cancer. Science. 2020;368:1290. - PubMed
5. 1. Sprague B.L., Lowry K.P., Miglioretti D.L., et al. Changes in mammography use by women’s characteristics during the first 5 months of the COVID-19 pandemic. J Natl Cancer Inst. 2021;113:1161–1167. - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3